LN2866839
98% , 1251765-07-7
| Pack Size | Price | Stock | Quantity |
| 100mg | RMB1268.80 | In Stock |
|
| 250mg | RMB2115.20 | In Stock |
|
| 1g | RMB4230.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 711.4±70.0 °C(Predicted) |
| Density | 1.75±0.1 g/cm3(Predicted) |
| solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
| form | Solid |
| pka | 13.26±0.70(Predicted) |
| color | White to Off-White |
| Stability: | Hygroscopic |
| InChI | InChI=1S/C14H22N6O4S/c1-2-5-25-14-16-12(15)9-13(17-14)20(19-18-9)7-6-8(24-4-3-21)11(23)10(7)22/h7-8,10-11,21-23H,2-6H2,1H3,(H2,15,16,17)/t7-,8+,10+,11-/m1/s1 |
| InChIKey | YTYBSYIHUFBLKV-YKDSUIRESA-N |
| SMILES | [C@@H]1(O)[C@@H](OCCO)C[C@@H](N2C3C(N=N2)=C(N)N=C(SCCC)N=3)[C@@H]1O |
| CAS DataBase Reference | 1251765-07-7 |
Description and Uses
AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |






![(3aR,4S,6R,6aS)-6-amino-2,2-dimethyl-hexahydrocyclopenta[d][1,3]dioxol-4-ol](https://img.chemicalbook.com/CAS2/GIF/155899-66-4.gif)
